Table 2.
Previous Treatments |
n (%) 77 (100) |
---|---|
Topical treatments | 10 (12.9) |
Methotrexate | 14 (18.2) |
Cyclosporine | 21 (27.3) |
Acitretin | 3 (3.9) |
NB-UVB | 4 (5.2) |
Dimethyl fumarate | 3 (3.9) |
Apremilast | 8 (10.4) |
Adalimumab | 2 (2.6) |
Ustekinumab | 2 (2.6) |
Secukinumab | 7 (9.1) |
Others (etanercept, brodalumab) | 3 (3.9) |